Wordt geladen...
Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy
Treatment of patients with newly diagnosed primary CNS lymphomas using high dose methotrexate regimens is reported to yield about 30% long term survivors with minimal neurotoxicity. As in other systemic large cell lymphomas, it is generally assumed that most relapses occur within 5 years of diagnosi...
Bewaard in:
| Gepubliceerd in: | CNS Oncol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Future Medicine Ltd
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4834699/ https://ncbi.nlm.nih.gov/pubmed/26507609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.15.34 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|